Anhedonia as a basic syndrome and a target for treatment for depressive disorder
The article presents an analytical review aimed at determining the effect of anhedonia on the course and therapeutic prognosis of depression. Currently, there is no specific pharmacological approach to the treatment of anhedonia in depression.It is clear all antidepressants that affect the symptoms...
Saved in:
Main Authors: | G. E. Mazo, A. O. Kibitov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-10-01
|
Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
Subjects: | |
Online Access: | https://www.bekhterevreview.com/jour/article/view/267 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing the diagnosis and treatment of depression in primary care: the emerging role of vortioxetine treatment
by: José Ángel Alcalá, et al.
Published: (2025-07-01) -
Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients
by: N. V. Filippova, et al.
Published: (2023-06-01) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
by: Li G, et al.
Published: (2016-02-01) -
Vortioxetine for depression treatment in hospital setting: experience from a single psychiatric hospital
by: O. V. Limankin, et al.
Published: (2020-10-01) -
Depressive disorder and quality of life in patients with cerebral microangiopathy
by: O. V. Vorob’eva, et al.
Published: (2020-03-01)